Variant report
Variant | nsv818109 |
---|---|
Chromosome Location | chr2:213164837-213169190 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:213165115..213165752-chr21:42883583..42884373,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1857796 | chr2:213164837-213164838 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs1857795 | chr2:213164907-213164908 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs536094302 | chr2:213164916-213164917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs188468713 | chr2:213164994-213164995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148432852 | chr2:213165006-213165007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs374522513 | chr2:213165013-213165014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs535533113 | chr2:213165016-213165017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs545116447 | chr2:213165056-213165057 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs537256303 | chr2:213165071-213165072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs73068251 | chr2:213165073-213165074 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs368036563 | chr2:213165098-213165099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs12466513 | chr2:213165136-213165137 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs73986925 | chr2:213165146-213165147 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs12466568 | chr2:213165148-213165149 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs17346933 | chr2:213165193-213165194 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs539449144 | chr2:213165196-213165197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs534407957 | chr2:213168669-213168670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs554385626 | chr2:213168697-213168698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs571005643 | chr2:213168721-213168722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs530249102 | chr2:213168762-213168763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs7588550 | chr2:213168768-213168769 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | disease |
22 | rs16848289 | chr2:213168797-213168798 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs368673646 | chr2:213168844-213168845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs566829747 | chr2:213168877-213168878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs34231570 | chr2:213168904-213168905 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs538997075 | chr2:213168921-213168922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs140379192 | chr2:213168966-213168967 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs571994697 | chr2:213168988-213168989 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs557459909 | chr2:213168997-213168998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs59043697 | chr2:213169008-213169009 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs78131946 | chr2:213169028-213169029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs543159828 | chr2:213169106-213169107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs144226965 | chr2:213169112-213169113 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs528902982 | chr2:213169143-213169144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs112040087 | chr2:213169158-213169159 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs562401795 | chr2:213169176-213169177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs7562228 | chr2:213169190-213169191 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Non-small cell lung cancer | 18676828 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 21147756 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Schizophrenia | 18990708 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:213164600-213165000 | Enhancers | Brain Anterior Caudate | brain |
2 | chr2:213164800-213165200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
3 | chr2:213168600-213168800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr2:213168800-213197200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |